Immunogenicity

Real-world Immunogenicity of Anti-IL5/5a Antibody

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

Influenza Vaccination Strategy for Patients With Hematologic Malignancy

A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30

Immunogenicity of COVID-19 Vaccine on Heterologous Schedule

Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS

Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study

Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2

New Generation mRNA Booster Vaccine Against Emerging VOCs

mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

EMaBS TB Vaccine Study

Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines